electroCore to Present at 2022 Maxim Virtual Growth Conference

electroCore announced that CEO Dan Goldberger will present at the 2022 Maxim Virtual Growth Conference from March 28-30, 2022.

Rhea-AI Summary

electroCore announced that CEO Dan Goldberger will present at the 2022 Maxim Virtual Growth Conference from March 28-30, 2022. The presentation will be available on-demand, providing insights into the company's advancements in bioelectronic medicine. electroCore focuses on non-invasive vagus nerve stimulation therapy for the treatment of conditions like migraines and cluster headaches. The company's solutions aim to improve patient outcomes in neurology. Stakeholders can access the presentation and more information via the provided link.

Argus Session date unavailable

+6.17% session move Open Argus

Details

News Market Reaction – ECOR

The recorded move for ECOR in the trading session of this news was +6.17%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will be presenting at the 2022 Maxim Virtual Growth Conference.

electroCore’s presentation will be available on-demand from March 28th - 30th, 2022. To view the presentation, click HERE.

About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its non-invasive vagus nerve stimulation therapy platform, initially focused on the treatment of multiple conditions in neurology. The company's current indications are the preventive treatment of cluster headache and migraine, the acute treatment of migraine and episodic cluster headache, the acute and preventive treatment of migraines in adolescents, and paroxysmal hemicrania and hemicrania continua in adults.

For more information, visit www.electrocore.com.

Investors:
Rich Cockrell
CG Capital
404-736-3838
ecor@cg.capital

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will electroCore present at the Maxim Virtual Growth Conference?

electroCore will present at the Maxim Virtual Growth Conference from March 28 to March 30, 2022.

Who is presenting electroCore's updates at the conference?

CEO Dan Goldberger will present electroCore's updates at the conference.

What is the focus of electroCore's presentation?

The presentation will focus on electroCore's advancements in bioelectronic medicine, particularly regarding migraine and cluster headache treatments.

How can I view electroCore's presentation?

electroCore's presentation will be available on-demand; you can view it by clicking the provided link from March 28-30, 2022.

What conditions does electroCore's therapy address?

electroCore's therapy addresses conditions such as migraines, cluster headaches, and related neurological disorders.